Generic Peptide APIs
Off-patent and patent-expiring peptide APIs for generic dossiers, supplied with batch-level analytical data.
View categoryHangzhou Thinheal Pharma-Tech Co., Ltd. was founded in 2019 in Hangzhou, China, as a biopharmaceutical company that integrates independent R&D, manufacturing and sales of peptide products with custom development and contract manufacturing. Our core management team combines a pharmaceutical background with nearly 20 years of hands-on management experience in the peptide industry — experience that directly shapes how we evaluate sequences, design synthesis routes and scale processes.
Thinheal operates its own R&D center and production base. Total production capacity for chemically synthesized peptides has reached the multi-ton level, placing Thinheal among the front-running peptide producers in the industry.


Thinheal runs a complete and efficient peptide R&D, production and sales system. That lets us deliver the full range of peptide industrialization services under one roof: peptide API development and production, customized peptide development and manufacturing (CDMO), and cosmetic peptide research and production — reducing hand-offs, tech-transfer risk and supplier-qualification workload for your team.
Chemically synthesized peptide APIs developed in-house and produced at our own base, with multi-ton aggregate capacity.
Project-based contract R&D, contract production and sales support for innovator and generic sponsors.
Functional peptides for skin-care and aesthetic brands, from sequence selection to supply.
Browse the categories international buyers source most often. Every category page lists available sequences with specifications; request the catalog for current grades and availability.
Off-patent and patent-expiring peptide APIs for generic dossiers, supplied with batch-level analytical data.
View categoryPharmaceutical peptides for metabolic, endocrine, gastrointestinal and other therapeutic development programs.
View categoryIncretin-based APIs such as Semaglutide (CAS 910463-68-2) for diabetes and weight-management pipelines.
View categoryGLP-2 receptor agonists for short bowel syndrome and intestinal-health development projects.
View categoryPeptides addressing gut motility, secretion and mucosal-repair pathways beyond the GLP-2 class.
View categorySpecialty peptide APIs outside the incretin families — ask our team about sequences not listed publicly.
View categorySignal, carrier and neurotransmitter-modulating peptides for anti-aging and advanced skin-care formulations.
View categoryThe peptides buyers request most frequently right now — fast-moving items with active supply.
View categoryWe provide one-stop customized R&D and production services from APIs to preparations for pharmaceutical companies worldwide. By focusing on products with high technical barriers and broad market prospects, we integrate R&D, production, registration support and commercialization — helping partners break through production bottlenecks, optimize process routes and accelerate time to market.
Commercial-scale peptide API supply backed by our own production base, with formulation development support so your program can move from API to finished dosage form with a single technical partner.
Research and production of cosmetic peptides for skin-care and aesthetic brands, supporting anti-aging, firming and repair claims with consistent, well-characterized raw materials.
Project-based contract research for novel or modified sequences: route design, synthesis feasibility, analytical method work and scale-up planning led by a team with deep peptide experience.
Our CDMO business covers project-based contract development, contract manufacturing and sales — one accountable partner from early development to commercial supply.
A transparent, four-stage workflow designed around how procurement, QA and regulatory teams actually qualify a peptide supplier.
Request the catalog, shortlist sequences and align on purity, grade and quantity requirements with your regional desk.
Review batch analytical data such as the Certificate of Analysis and evaluate samples against your internal specifications.
Our team supports questionnaires, documentation requests and audits so QA can approve Thinheal as a supplier.
Scheduled production from our multi-ton capacity base, with a dedicated contact for logistics and ongoing orders.
What differentiates Thinheal when buyers compare peptide API manufacturers.
Chemical synthesis know-how built over nearly two decades of peptide industry leadership, applied to difficult sequences, long-chain analogues and modified peptides where process control defines quality and yield.
Learn more →An in-house R&D center focused on products with high technical barriers and strong market outlooks, continuously optimizing process paths to reduce cost of goods and improve batch-to-batch consistency.
Learn more →Multi-ton total capacity for chemically synthesized peptides positions Thinheal at the forefront of the industry — giving buyers supply security for commercial launches and long-term contracts.
Learn more →Straight answers to the questions procurement and QA teams ask first when evaluating a peptide API manufacturer.
Thinheal supplies generic peptide APIs, therapeutic peptides, GLP-1 analogues such as Semaglutide (CAS 910463-68-2), GLP-2 analogues, other gastrointestinal peptides, other therapeutic peptide APIs and cosmetic peptides for skin-care formulations. See the full product range.
Yes. Our CDMO business covers project-based contract research and development, contract manufacturing and sales support — including custom peptide development, process optimization, scale-up and commercial API supply through to formulation development.
Thinheal operates an R&D center and a production base in Hangzhou, China. Total production capacity for chemically synthesized peptides has reached the multi-ton level, supporting both development-stage and commercial-volume orders.
Shipments are accompanied by batch analytical data such as a Certificate of Analysis. Additional documents needed for supplier qualification or regulatory filings can be scoped with our sales and technical team for each project.
Thinheal runs dedicated desks for USA & Europe, Russia & CIS & Europe, Asia, and the Middle East & East Asia — see the contact section below, or email [email protected] and we will route your request.
Practical guidance for buyers evaluating peptide API manufacturers and CDMO partners.




We uphold a philosophy of professionalism, backed by a young, responsive team. Share your target sequence, grade and annual volume — the right regional desk will reply with specifications and next steps.